title: Target practice in severe asthma.
abstract: The NLRP3 inflammasome/caspase-1/IL-1β axis may be a therapeutic target in severe steroid-resistant asthma.
authors.affiliation: Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA. Email: stephanie.christenson@ucsf.edu.
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Christenson
mesh_terms: D001249:Asthma; D020170:Caspase 1; D006801:Humans; D058847:Inflammasomes; D053583:Interleukin-1beta; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein
chemical_list: D058847:Inflammasomes; D053583:Interleukin-1beta; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human; D020170:Caspase 1